• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

'Tiered' Insurance Confounds Consumers, Docs In Mass.


Sarah Bechta, a wife, mother and physician from Northborough, Mass. sat down at her kitchen table with a folder full of brochures, pages from insurance websites and a hand-drawn spreadsheet to try to find out if a new "tiered" health plan would be the cheapest option for her family.

She started by comparing her premium for traditional insurance and a tiered plan. Tiered insurance is being offered by various companies in Massachusetts as a way to meet employers’ demands for cheaper insurance premiums.

A tiered plan would cut Bechta’s premium in half and "would save about $1,400 a year. It made me stop and think," she said.

But would she actually save that $1,400 or would it be eaten up in higher co-payments and deductibles?

"That was the thing that was really hard to predict. I could not figure it out," Bechta said, even though, as a doctor, Bechta believes that she's "as capable, or more capable, than everybody else who's looking at this information."

Read the full story at: http://tinyurl.com/6pa9grn

Sources: WBUR, NPR, Kaiser Health News

Related Videos
David Andorsky, MD, Rocky Mountain Cancer Center
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology
Video 7 - "Future Opportunities in Genitourinary Cancers"
Video 6 - "LITESPARK-003 Trial Insights: Updates from ESMO 2023"
Video 5 - "Key Highlights from EV-302 Study at ESMO 2023"
Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.
Andrew Srisuwananukorn, MD
Dr Jennifer Brown
Related Content
© 2023 MJH Life Sciences
All rights reserved.